Interstitial Lung Disease Associated with Systemic Sclerosis
Seminars in Respiratory and Critical Care Medicine · 01.06.2024 · 45 (03) · 342-364
DOI: 10.1055/s-0044-1786698 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.06.2024. Verfasst von Valentine Mismetti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civ…. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Scleroderma, Systemic, Immunosuppressive Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 181 Literaturangaben.
Abstract (Originalsprache)
Systemic sclerosis (SSc) is a rare autoimmune disease characterized by a tripod combining vasculopathy, fibrosis, and immune-mediated inflammatory processes. The prevalence of interstitial lung disease (ILD) in SSc varies according to the methods used to detect it, ranging from 25 to 95%. The fibrotic and vascular pulmonary manifestations of SSc, particularly ILD, are the main causes of morbidity and mortality, contributing to 35% of deaths. Although early trials were conducted with cyclophosphamide, more recent randomized controlled trials have been performed to assess the efficacy and tolerability of several medications, mostly mycophenolate, rituximab, tocilizumab, and nintedanib. Although many uncertainties remain, expert consensus is emerging to optimize the therapeutic management and to provide clinicians with evidence-based clinical practice guidelines for patients with SSc-ILD. This article provides an overview, in the light of the latest advances, of the available evidence for the diagnosis and management of SSc-ILD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
- INSA-Lyon, University of Lyon, University Claude-Bernard Lyon 1, Lyon, France.
- Radiology Department, Hospices Civils de Lyon, Lyon, France.
- UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France.
ORCID-Profile: Valentine Mismetti, Salim Si-Mohamed, Vincent Cottin
Zitieren
APA
Mismetti, V., Si-Mohamed, S., & Cottin, V. (2024). Interstitial Lung Disease Associated with Systemic Sclerosis. Seminars in Respiratory and Critical Care Medicine, 45(03), 342-364. https://doi.org/10.1055/s-0044-1786698
Vancouver
Mismetti V, Si-Mohamed S, Cottin V. Interstitial Lung Disease Associated with Systemic Sclerosis. Seminars in Respiratory and Critical Care Medicine. 2024;45(03):342-364. doi:10.1055/s-0044-1786698
BibTeX
@article{Mismetti2024,
author = {Mismetti, Valentine and Si-Mohamed, Salim and Cottin, Vincent},
title = {Interstitial Lung Disease Associated with Systemic Sclerosis},
journal = {Seminars in Respiratory and Critical Care Medicine},
year = {2024},
volume = {45},
number = {03},
pages = {342--364},
doi = {10.1055/s-0044-1786698}
}
EUVIMED